Financhill
Buy
61

CAJPY Quote, Financials, Valuation and Earnings

Last price:
$29.87
Seasonality move :
2.07%
Day range:
$29.27 - $29.42
52-week range:
$26.25 - $34.69
Dividend yield:
0%
P/E ratio:
23.97x
P/S ratio:
0.88x
P/B ratio:
1.20x
Volume:
37.1K
Avg. volume:
59.9K
1-year change:
-11.8%
Market cap:
$25.7B
Revenue:
$29.8B
EPS (TTM):
$1.22

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Canon, Inc. has 9.25% upside to fair value with a price target of -- per share.

CAJPY vs. S&P 500

  • Over the past 5 trading days, Canon, Inc. has overperformed the S&P 500 by 0.46% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Canon, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Canon, Inc. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Canon, Inc. reported revenues of $7.5B.

Earnings Growth

  • Canon, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Canon, Inc. reported earnings per share of $0.49.
Enterprise value:
31B
EV / Invested capital:
0.99x
Price / LTM sales:
0.88x
EV / EBIT:
10.26x
EV / Revenue:
1.01x
PEG ratio (5yr expected):
2.04x
EV / Free cash flow:
16.27x
Price / Operating cash flow:
14.15x
Enterprise value / EBITDA:
6.73x
Gross Profit (TTM):
$14.4B
Return On Assets:
3.22%
Net Income Margin (TTM):
4.15%
Return On Equity:
5.38%
Return On Invested Capital:
4.2%
Operating Margin:
7.97%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $30B $29.3B $30.7B $7.2B $7.5B
Gross Profit $14B $13.9B $14.4B $3.5B $3.5B
Operating Income $2.6B $2.7B $3B $657.8M $597M
EBITDA $4.3B $4.3B $4.6B $1.1B $1B
Diluted EPS $1.91 $2.03 $1.22 $0.48 $0.49
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $17B $15.9B $16.5B $17.1B $18B
Total Assets $42.6B $36.6B $37.7B $40.1B $40.7B
Current Liabilities $12.1B $9.3B $11.6B $12.3B $13B
Total Liabilities $16.1B $13.5B $14B $15.6B $17.5B
Total Equity $26.5B $23.2B $23.7B $24.5B $23.3B
Total Debt $643.1M $1.8B $615.3M $1.4B $2.6B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $2.5B $3.6B $3.6B $752.1M $857.3M
Cash From Investing -$1.8B -$1.8B -$1.9B -$331.6M -$444.5M
Cash From Financing -$433.5M -$1.6B -$762.9M -$514.8M -$593.1M
Free Cash Flow $934.3M $2B $1.9B $390.3M $415.4M
CAJPY
Sector
Market Cap
$25.7B
$53.5M
Price % of 52-Week High
84.43%
58.89%
Dividend Yield
0%
0%
Shareholder Yield
5.51%
--
1-Year Price Total Return
-11.8%
-12.83%
Beta (5-Year)
0.589
0.668
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
1 years

Technicals

8-day SMA
Sell
Level $29.42
200-day SMA
Sell
Level $29.91
Bollinger Bands (100)
Buy
Level 28.45 - 29.97
Chaikin Money Flow
Buy
Level 119.7M
20-day SMA
Buy
Level $29.00
Relative Strength Index (RSI14)
Buy
Level 52.53
ADX Line
Sell
Level 9.35
Williams %R
Neutral
Level -30.8411
50-day SMA
Buy
Level $29.11
MACD (12, 26)
Buy
Level 0.12
25-day Aroon Oscillator
Buy
Level 72
On Balance Volume
Sell
Level -3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.5568)
Buy
CA Score (Annual)
Level (0.6714)
Buy
Beneish M-Score (Annual)
Level (-2.9655)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.9812)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Canon, Inc. engages in the development, manufacture and sale of office multifunction devices, copying machines, printers, cameras and lithography equipment. It operates through the following business segments: Printing Business, Imaging Business, Medical Business, Industrial Business and Others. The Printing business segment offers MFDs, printers, copying machines for personal and office use and production print products for print professionals. The Imaging business segment manufactures and markets digital cameras and digital video camcorders, as well as lenses and various related accessories. The Medical business segment covers the diagnostic imaging equipment, from CT and MRI systems to ophthalmic and digital radiography equipment. The Industrial business segment develops and manufactures Semiconductor and flat panel display lithography equipment, digital radiography systems, ophthalmic equipment, vacuum thin-film deposition equipment, organic light-emitting diode panel manufacturing equipment, micro motors, computers, handy terminals and document scanners. The Others segment offers handy terminals and document scanners. The company was founded on August 10, 1937 and is headquartered in Tokyo, Japan.

Stock Forecast FAQ

In the current month, CAJPY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CAJPY average analyst price target in the past 3 months is --.

  • Where Will Canon, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Canon, Inc. share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Canon, Inc.?

    Analysts are divided on their view about Canon, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Canon, Inc. is a Sell and believe this share price will drop from its current level to --.

  • What Is Canon, Inc.'s Price Target?

    The price target for Canon, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CAJPY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Canon, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CAJPY?

    You can purchase shares of Canon, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Canon, Inc. shares.

  • What Is The Canon, Inc. Share Price Today?

    Canon, Inc. was last trading at $29.87 per share. This represents the most recent stock quote for Canon, Inc.. Yesterday, Canon, Inc. closed at $29.29 per share.

  • How To Buy Canon, Inc. Stock Online?

    In order to purchase Canon, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 2.24% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 7.01% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock